Hi friends, and happy new year,
In my continuing series on my blog, bkoffman.blogspot.com about why our voices need to be heard at professional cancer and hematology congresses where patients are rarely on the podiums, this time I speak to my appraisal of the particular important concerns for those of us with CLL.
Please let me know if you agree and what I missed.
Thanks
Stay strong
We are all in this together
Brian
Obinutuzumab was approved for treatment naive patients, but in only in combination with chlorambucil.Me and my CAR-T- Part 1 on why I have moved to Seattle for 2 monthsDr. O'Brien on Trial Design, CT scans and the one and only place for FCR.Venetoclax (ABT-199) Receives Breakthrough Therapy Designation In Relapsed Or Refractory CLL In Previously Treated 17p deletion PatientsAnother CLL patient dies disease free from complications of her treatment.
